Identification and evaluation of novel protective antigens for the development of a candidate TB subunit vaccine
The development of a vaccine against tuberculosis (TB), a disease caused by Mycobacterium tuberculosis (M.tb), is urgently needed. The only currently available vaccine, BCG, has variable efficacy. One approach in the global vaccine development effort is focused on boosting BCG using subunit vaccines...
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Langue: | English |
| Publié: |
American Society for Microbiology
2018
|